-transparent.png){kind=logo}
Augmentation of specific immunity is one of the most promising immunotherapeutical approaches against solid tumors. Protocols using autologous tumor cells or tumor associated antigens are easily performed and not charged by severe side effects. Recently some clinical trials suggested good results from immunotherapeutical protocols applied as an adjuvant to surgery in terms of disease free interval, survival and progression time in different stages. In this review the authors report the results of the most important clinical trials of vaccinetherapy in solid tumors. Little is known about the possibility of this new approach to oncology since we are at the real beginning of a new clinical treatment but in the considered trial its effectiveness seems to suggest a future wider application.
F Tagliaferri, and
I Sirovich, and
F Stipa, and
M G Valente, and
G Pupelis, and
S Tremiterra
March 1978,
Virginia medical,
F Tagliaferri, and
I Sirovich, and
F Stipa, and
M G Valente, and
G Pupelis, and
S Tremiterra
January 1976,
Annals of the New York Academy of Sciences,
F Tagliaferri, and
I Sirovich, and
F Stipa, and
M G Valente, and
G Pupelis, and
S Tremiterra
January 2004,
Voprosy onkologii,
F Tagliaferri, and
I Sirovich, and
F Stipa, and
M G Valente, and
G Pupelis, and
S Tremiterra
June 2009,
Cancer immunology, immunotherapy : CII,
F Tagliaferri, and
I Sirovich, and
F Stipa, and
M G Valente, and
G Pupelis, and
S Tremiterra
January 1989,
Seminars in surgical oncology,
F Tagliaferri, and
I Sirovich, and
F Stipa, and
M G Valente, and
G Pupelis, and
S Tremiterra
January 2021,
Theranostics,
F Tagliaferri, and
I Sirovich, and
F Stipa, and
M G Valente, and
G Pupelis, and
S Tremiterra
January 1976,
Canadian journal of surgery. Journal canadien de chirurgie,
F Tagliaferri, and
I Sirovich, and
F Stipa, and
M G Valente, and
G Pupelis, and
S Tremiterra
April 2009,
Seminars in radiation oncology,
F Tagliaferri, and
I Sirovich, and
F Stipa, and
M G Valente, and
G Pupelis, and
S Tremiterra
October 2003,
Expert review of anticancer therapy,
F Tagliaferri, and
I Sirovich, and
F Stipa, and
M G Valente, and
G Pupelis, and
S Tremiterra
October 1976,
Lancet (London, England),
